Telehealth support for hormone therapy side effects in breast cancer
Treatments studied
This study tests a telehealth program to help patients manage symptoms and stay on their hormone therapy after breast cancer treatment. It may help with side effects and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be female
- Be at least 21 years old
- Have early-stage (0 to IIIB), hormone receptor positive breast cancer
- Have completed primary treatment (surgery, chemotherapy, or radiation)
- Be between 3 and 12 months into adjuvant endocrine therapy
- Report distress related to endocrine therapy of 4 or higher on a 0-10 scale
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a digital tool (a smartphone app) to help women and men with early breast cancer manage side effects from hormone therapy. The goal is to improve quality of life during treatment.
This trial tests a mobile health program to help women manage symptoms and stay healthy while taking hormone therapy (like tamoxifen or anastrozole) for early-stage breast cancer. It involves using a smartphone app and an electronic pill bottle to track your health and medication.
This trial tests if tracking how you feel and reporting your symptoms can help women with hormone receptor-positive breast cancer take their hormone-blocking medication more consistently. It may be a good fit if you have been prescribed aromatase inhibitors or similar therapy and have had trouble taking it as directed.
This trial tests a structured nursing and education program to support people with non-metastatic breast cancer who take hormone-blocking treatment. It may help you manage side effects and stay supported during follow-up, using online questionnaires and scheduled sessions.
This trial tests a smartphone app called Sidekick to help women with early-stage breast cancer stick to their hormone therapy and feel more confident managing their health. If you were diagnosed with stage I, II, or III breast cancer after September 2023 and are starting hormone therapy, this program might help you stay on track.
This study tests if a text message program can help Latina breast cancer patients remember to take their hormone therapy pills. It also looks at how non-medical challenges (like money or housing issues) affect medication taking.
Hear when a new Hormone-receptor-positive Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.